Clinical Trials Logo

Clinical Trial Summary

This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.


Clinical Trial Description

The purpose of the study is to see if Belotero® Soft is safe and effective for correction of mild facial wrinkles, such as nasolabial folds. The second objective of the study is to see if Belotero® Soft works better than the active comparator. Subjects will receive Belotero® Soft injection to one side of the face and the active comparator to the other side of the face. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00877279
Study type Interventional
Source Merz Pharmaceuticals, LLC
Contact
Status Completed
Phase Phase 3
Start date November 2007
Completion date March 2008

See also
  Status Clinical Trial Phase
Completed NCT01447342 - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines Phase 2/Phase 3
Completed NCT00978887 - Retorna Facial Cream in the Treatment of Facial Wrinkles Phase 3
Completed NCT00414544 - Evaluation of the Safety and Efficacy of CosmetaLifeā„¢ for the Correction of Nasolabial Folds Phase 2
Completed NCT00888914 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT01124565 - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00922623 - Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI N/A
Not yet recruiting NCT03836638 - The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment N/A
Not yet recruiting NCT06322875 - A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection N/A
Completed NCT01566396 - Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles N/A
Completed NCT01151436 - Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers N/A
Completed NCT06321770 - Oral Supplementation With Active Collagen Peptides and Skin Health Improvement N/A
Completed NCT01379365 - Cryo-Touch III Refinement Study Investigational Plan Phase 2/Phase 3
Completed NCT00288470 - A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast. N/A
Completed NCT02122536 - Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles N/A
Completed NCT01167140 - Cryo-Touch II for the Treatment of Wrinkles Phase 2/Phase 3
Completed NCT00968825 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT03286283 - The Use of J-Plasma® for Dermal Resurfacing N/A
Completed NCT01064518 - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00417469 - A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs) Phase 3
Completed NCT00293163 - A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique. Phase 4